Write in a clean editor, then format for Surgical Oncology Insight in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Surgical Oncology Insight is a peer-reviewed journal published by Elsevier, covering Pancreatic and Hepatic Oncology Research, Intraperitoneal and Appendiceal Malignancies, Gastric Cancer Management and Outcomes.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Surgical Oncology Insight 12 (2023) 45–58.
Formats any DOI in Surgical Oncology Insight style. No sign-up. |
| Publishes research in | Pancreatic and Hepatic Oncology Research Intraperitoneal and Appendiceal Malignancies Gastric Cancer Management and Outcomes Breast Cancer Treatment Studies Colorectal Cancer Surgical Treatments |
| ISSN | 2950-2470 |
| Citation impact (2-yr) | 1.09 |
| h-index | 7 |
| i10-index | 1 |
| Total citations | 254 |
| Top institutions publishing here | Memorial Sloan Kettering Cancer Center |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Over the last several decades, the treatment of breast cancer has evolved from a reliance on radical surgery to less invasive treatments incorporating systemic therapy (e.g., chemotherapy and endocrine therapy) and radiotherapy, which has allowed for breast conservation surgery and improved survival. Accordingly, the management of breast cancer today is perhaps the best example of…
Cancers of the oral cavity are common worldwide, with incidence rates and trends varying significantly between different regions. Globally, approximately 378,000 cases were diagnosed with 178,000 deaths in 2020.1 In the United States, the estimated annual incidence of oral cavity squamous cell carcinoma (OCSCC) is reported to have decreased from 3.78 per 100,000 in 2001…
<h2>Abstract</h2> Hepatocellular carcinoma (HCC) is a highly morbid tumor with diverse genomic heterogeneity that poses a major therapeutic barrier. Systemic immunotherapy is often considered in the treatment of advanced HCC, but immunotherapy has been limited by high rates of resistance and immune evasion. Newer studies have explored the combination of locoregional treatments (LRTs), a common…
BackgroundThe COVID-19 pandemic posed an unprecedented global threat to healthcare systems, causing delays in colorectal cancer (CRC) diagnoses. This study aims to assess the impact of COVID-19 on the presentation of cancer stages in the U.S.MethodsData from the national cancer database (2015-2020) were analyzed, categorizing patients into pre-COVID (2015-2019) and COVID (2020) groups for evaluation.ResultsIn…
BackgroundMalignant pleural effusions (MPE) and malignant ascites (MA) are serious complications of advanced cancer, marked by debilitating symptoms and limited treatment options. Based on a wealth of previous literature implicating the cytokine IL-6 as a central mediator in the pathogenesis of MPE and MA, the Regional Immuno-Oncology Trial 2 (RIOT-2) clinical protocol was developed to…
